SecBot SecBot
SECBOTREPLAY Home › Report › PCVX

PCVX · Vaxcyte announced the retirement of board member Jacks Lee and the…

Vaxcyte, Inc. · 8-K filed Jun 23, 2026 at 16:09 ET

At the news

NEUTRALIMPACT 2/10

8-K filed Jun 23, 2026 at 16:09 ET

Vaxcyte announced the retirement of board member Jacks Lee and the appointment of Moncef Slaoui as an independent Class II director, effective June 17, 2026. Dr. Slaoui will receive standard non-employee director compensation, including an annual equity grant currently valued at $430,000. This is a routine governance filing with no material financial or operational impact.

  • Director Jacks Lee retired effective June 17, 2026; will remain as a consultant on supply and manufacturing.
  • Moncef Slaoui appointed as an independent Class II director; term expires at the 2028 annual meeting.
  • Dr. Slaoui receives standard director compensation; annual equity grant is currently set at $430,000.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access